Eastman Chemical
691 hedge funds and large institutions have $11.3B invested in Eastman Chemical in 2017 Q4 according to their latest regulatory filings, with 111 funds opening new positions, 231 increasing their positions, 223 reducing their positions, and 38 closing their positions.
192% more first-time investments, than exits
New positions opened: 111 | Existing positions closed: 38
11% more funds holding
Funds holding: 622 → 691 (+69)
1.6% more ownership
Funds ownership: 83.51% → 85.11% (+1.6%)
4% more repeat investments, than reductions
Existing positions increased: 231 | Existing positions reduced: 223
3% more capital invested
Capital invested by funds: $10.9B → $11.3B (+$374M)
14% less call options, than puts
Call options by funds: $86.2M | Put options by funds: $100M
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
+$152M |
| 2 |
UBS AM
Chicago,
Illinois
|
+$103M |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$53.9M |
| 4 |
Morgan Stanley
New York
|
+$53.4M |
| 5 |
EIP
Epoch Investment Partners
New York
|
+$42.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$126M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$117M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
-$59.7M |
| 4 |
Bank of New York Mellon
New York
|
-$55.8M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$41.2M |
EMN Hedge Fund Activity: Q4 2017 in Review
691 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Eastman Chemical (EMN) for Q4 2017, worth a combined $11.3B — up 3.4% from $10.9B a quarter earlier.
Buyers outnumbered sellers: 111 funds opened new EMN positions and 38 closed out — a net gain of 73 holders — while 231 added to existing stakes and 223 trimmed.
The largest buyer was Victory Capital Management, adding an estimated $152M. The largest seller was T. Rowe Price Associates, cutting an estimated $126M.
- 691 institutional investors held Eastman Chemical (EMN) as of Q4 2017, up from 622 in Q3 2017.
- Funds reported $11.3B of Eastman Chemical stock for Q4 2017, up 3.4% quarter-over-quarter.
- 111 funds opened new Eastman Chemical positions in Q4 2017 and 38 closed out, a net change of +73 holders.
- The largest Eastman Chemical buyer in Q4 2017 was Victory Capital Management, an estimated $152M added.
- The largest Eastman Chemical seller in Q4 2017 was T. Rowe Price Associates, an estimated $126M sold.
Based on aggregated 13F filings for Q4 2017.